---
figid: PMC9052234__10.1177_11772719221095676-fig2
figtitle: 'Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical
  Application'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9052234
filename: 10.1177_11772719221095676-fig2.jpg
figlink: /pmc/articles/PMC9052234/figure/fig2-11772719221095676/
number: F2
caption: Summary representation of current data revealing implication of different
  cytokines in AAA. (A) Aneurysm samples collected from patients are characterized
  by expression of pro-inflammatory cytokines on the transcriptome and protein levels.
  (B) Study on mice show that pharmacological or genetic blockade of L-10, IL-33,
  and canonical TGF-β signaling aggravate AAA course, whereas inhibition of TNF-α,
  IL-1β, IL-6, IL-12/IL-23, IL-17, CCR2, CXCR2, CXCR4 and the TGF-β noncanonical pathway
  attenuate the disease. At the same time, animal studies show controversial role
  of IL-4, IFN-γ and CXCL10. (C) Population genetics studies revealed that carriers
  of particular mutations of genes CCR2 (rs1799864), CCR5 (Delta-32), IL6 (rs1800796
  and rs1800795), IL6R (rs12133641), IL10 (rs1800896), TGFB1 (rs1800469), TGFBR1 (rs1626340),
  TGFBR2 (rs1036095, rs4522809, rs1078985), and TNFA (rs1800629) have increased risk
  of AAA development.
papertitle: 'Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical
  Application.'
reftext: Olesya A Puchenkova, et al. Biomark Insights. 2022;17:11772719221095676.
year: '2022'
doi: 10.1177/11772719221095676
journal_title: Biomarker Insights
journal_nlm_ta: Biomark Insights
publisher_name: SAGE Publications
keywords: Aneurysm | AAA | cytokines | inflammation | TGF-β | IL-6
automl_pathway: 0.9219701
figid_alias: PMC9052234__F2
figtype: Figure
redirect_from: /figures/PMC9052234__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9052234__10.1177_11772719221095676-fig2.html
  '@type': Dataset
  description: Summary representation of current data revealing implication of different
    cytokines in AAA. (A) Aneurysm samples collected from patients are characterized
    by expression of pro-inflammatory cytokines on the transcriptome and protein levels.
    (B) Study on mice show that pharmacological or genetic blockade of L-10, IL-33,
    and canonical TGF-β signaling aggravate AAA course, whereas inhibition of TNF-α,
    IL-1β, IL-6, IL-12/IL-23, IL-17, CCR2, CXCR2, CXCR4 and the TGF-β noncanonical
    pathway attenuate the disease. At the same time, animal studies show controversial
    role of IL-4, IFN-γ and CXCL10. (C) Population genetics studies revealed that
    carriers of particular mutations of genes CCR2 (rs1799864), CCR5 (Delta-32), IL6
    (rs1800796 and rs1800795), IL6R (rs12133641), IL10 (rs1800896), TGFB1 (rs1800469),
    TGFBR1 (rs1626340), TGFBR2 (rs1036095, rs4522809, rs1078985), and TNFA (rs1800629)
    have increased risk of AAA development.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCR4
  - CXCL8
  - PDGFA
  - CCL5
  - TNF
  - IL6
  - IL1A
  - IL1B
  - LTA
  - CXCL5
  - IL10
  - CCL8
  - CXCL1
  - CCL2
  - CSF1
  - CSF3
  - IL33
  - TGFB1
  - TGFB2
  - TGFB3
  - IL18
  - IL12A
  - IL12B
  - IL37
  - IL23A
  - IL17A
  - CCR2
  - CXCR2
  - IL4
  - CXCL10
  - TGFBR2
  - TGFBR1
  - IL6R
  - CCR5
  - IL13
  - IL2
  - PDGFB
  - PDGFC
  - PDGFD
---
